Subcutaneous delivery tool
Summary by NHIP
Subcutaneous Implantation System
The system implants a medical device by pushing it through a tool body channel using a sliding plunger. A lateral opening in the second tool portion allows visualization of the device and plunger from the side while the first portion extends distally from the second portion.
Claim Score by NHIP
Abstract
Subcutaneous implantation tools and methods of implanting a subcutaneous device using the same. The tool may include a tool body having a longitudinally extending recess having a distal opening and having a tunneler at a distal end of the tool body extending from the distal opening of the recess. The tool may include a plunger slidably fitting within at least a portion of the tool body recess. The recess may be configured to receive an implantable device and the tunneler preferably extends distally from the recess at a position laterally displaced from the device when the device is so located in the recess. Movement of the plunger distally within the recess advances the device distally out of the recess and alongside of and exterior to the tunneler.

Term
7.5 yearsleft in the term
Expires 11 March 2034.
- Priority
- Filed
- Granted
- Today
- Expires
30 claims: 4 independent, 26 dependent
- 1A system comprising:a medical device comprising a first electrode;and an implantation tool for implanting the medical device in subcutaneous tissue, the tool comprising: a tool body defining a longitudinal axis and a channel extending along the longitudinal axis, the channel having a distal opening, wherein the tool body is configured to receive the medical device within the channel;and a plunger slidably fitting within the channel and movable within the channel towards the distal opening, wherein the plunger is configured to push a proximal end of the medical device out of the channel through the distal opening, wherein a portion of a lateral surface of the tool body defines a lateral opening, separate from the distal opening, to allow visualization of at least a portion of an entire length of the medical device within the channel from a position lateral to the tool body, the entire length of the medical device extending from a proximal end of the medical device to a distal end of the medical device, and wherein the lateral opening allows visualization of at least a portion of the plunger within the channel from a position lateral to the tool body, wherein the tool body comprises: a first portion comprising a first proximal end and a first distal end;and a second portion including the portion of the lateral surface of the tool body that defines the lateral opening, the second portion comprising a second proximal end and a second distal end, wherein the first proximal end of the first portion adjoins the second distal end of the second portion, and the first portion extends distally from the second distal end of the second portion, wherein each dimension of a cross section of the first portion at the first proximal end in a first plane orthogonal to the longitudinal axis is less than each corresponding dimension of a cross section of the second portion at the second distal end in a second plane orthogonal to the longitudinal axis, wherein the second portion defines the channel, and wherein a top surface of the first portion extends from a bottom surface of the channel as a continuance of the bottom surface along the longitudinal axis.
- 8Broadest claimClaim Score 30, narrow(NHIP)A system comprising:an insertable cardiac monitor (ICM) comprising two electrodes and configured to monitor an electrocardiogram of a patient via the two electrodes;and an implantation tool for implanting the ICM in subcutaneous tissue of the patient, wherein the implantation tool comprises: a tunneler comprising a first proximal end and a first distal end;an implantation tool handle comprising a second proximal end and a second distal end, wherein the implantation tool handle defines a channel extending along a longitudinal axis of the implantation tool, the channel having a distal opening at the second distal end and a proximal opening at the second proximal end, wherein the implantation tool handle is configured to receive the ICM within the channel;and a plunger configured to move in the channel through the proximal opening of the channel, wherein the plunger is configured to push the ICM out of the channel through the distal opening, wherein the implantation tool handle defines a lower opening, separate from the distal opening, on a portion of a lower surface of the handle, wherein the ICM can be observed within the channel through the lower opening, wherein the tunneler extends distally from the implantation tool handle such that the first proximal end adjoins the second distal end, wherein a longest dimension of a cross section of the tunneler is shorter than a longest dimension of a cross section of the implantation tool handle, wherein the cross section of the tunneler and the cross section of the implantation tool handle correspond to a plane orthogonal to the longitudinal axis in which the first proximal end of the tunneler adjoins the second distal end of the implantation tool handle, and wherein a top surface of the tunneler extends from a bottom surface of the channel as a continuance of the bottom surface along the longitudinal axis.
- 29A system comprising:an insertable cardiac monitor (ICM) comprising a plurality of electrodes and configured to monitor an electrocardiogram of a patient via the electrodes;an implantation tool for implanting the ICM in subcutaneous tissue of a patient, wherein the implantation tool comprises: a tunneler comprising a first proximal end and a first distal end;an implantation tool handle comprising a second proximal end and a second distal end, wherein the implantation tool handle defines a channel extending along a longitudinal axis of the implantation tool, the channel having a distal opening at the second distal end and a proximal opening at the second proximal end, wherein the implantation tool handle is configured to receive the ICM within the channel;a plunger configured to move in the channel through the proximal opening of the channel, wherein the plunger comprises: a distal plunger portion configured to move in the channel;and a proximal plunger portion, wherein a cross-section of the proximal plunger portion at a distal end of the proximal plunger portion is larger than a cross-section of the distal plunger portion at a proximal end of the distal plunger portion, wherein the plunger is configured to push the ICM out of the channel through the distal opening, wherein the implantation tool handle defines a lower opening, separate from the distal opening, on a portion of a lower surface of the handle, wherein the ICM can be observed within the channel through the lower opening, wherein the tunneler extends distally from the implantation tool handle such that the first proximal end adjoins the second distal end, wherein a longest dimension of a cross section of the tunneler is shorter than a longest dimension of a cross section of the implantation tool handle, and wherein the cross section of the tunneler and the cross section of the implantation tool handle correspond to a plane orthogonal to the longitudinal axis in which the first proximal end of the tunneler adjoins the second distal end of the implantation tool handle, and wherein a top surface of the tunneler extends from a bottom surface of the channel as a continuance of the bottom surface along the longitudinal axis;and an incision tool comprising: an incision tool handle;and a blade extending from a distal end of the incision tool handle.
- 30A system comprising:an insertable cardiac monitor (ICM) for monitoring an electrocardiogram of a patient;an implantation tool for implanting the ICM in subcutaneous tissue of the patient, wherein the implantation tool comprises: a tunneler comprising a first proximal end and a first distal end;an implantation tool handle comprising a second proximal end and a second distal end, wherein the implantation tool handle defines a channel extending along a longitudinal axis of the implantation tool, the channel having a distal opening at the second distal end and a proximal opening at the second proximal end, wherein the implantation tool handle is configured to receive the ICM within the channel;means for moving the ICM through the channel, wherein the means for moving the ICM through the channel comprises: a distal portion configured to move in the channel;and a proximal portion, wherein a cross-section of the proximal portion at a distal end of the proximal portion is larger than a cross-section of the distal portion at a proximal end of the distal portion, wherein the means for moving the ICM through the channel is configured to push the ICM out of the channel through the distal opening, wherein the implantation tool handle defines a lower opening, separate from the distal opening, on a portion of a lower surface of the handle, wherein the ICM can be observed within the channel through the lower opening, wherein the tunneler extends distally from the implantation tool handle such that the first proximal end adjoins the second distal end, wherein a longest dimension of a cross section of the tunneler is shorter than a longest dimension of a cross section of the implantation tool handle, wherein the cross section of the tunneler and the cross section of the implantation tool handle correspond to a plane orthogonal to the longitudinal axis in which the first proximal end of the tunneler adjoins the second distal end of the implantation tool handle, and wherein a top surface of the tunneler extends from a bottom surface of the channel as a continuance of the bottom surface along the longitudinal axis;an incision tool comprising: an incision tool handle;and a blade extending from a distal end of the incision tool handle;and a sterile package, wherein the ICM, the implantation tool, and the incision tool are included within the sterile package.
Independent claims4
48 paragraphs in 4 sections, as filed
0001This application is a continuation of U.S. patent application Ser. No. 14/204,227, filed Mar. 11, 2014, which claims the benefit of U.S. Provisional Application No. 61/788,940, filed Mar. 15, 2013. The entire content of each of these applications is incorporated herein by reference.
BACKGROUND
0002The use of monitoring equipment to measure various physical parameters of a patient is well known. There is a growing demand for using subcutaneous monitoring devices, which allow doctors to obtain information without a patient being connected to an external machine and/or which may otherwise not be reproducible in office settings. The term subcutaneous generally implies locations within the body of a patient under the skin and exterior to the musculature beneath the skin. For example, an implantable device that includes the ability to monitor a patient's heart beat in order to detect transient symptoms suggesting cardiac arrhythmia allows doctors to review data over a longer period of time than using external monitoring equipment in a simulated testing situation. However, to successfully implant implantable subcutaneous devices an implantation tool should, for example, ensure that the device is not implanted in muscle, reduce contact between the surgeon and the wound, be used in an office setting to minimize patient discomfort and the need for invasive surgery and have the ability to repeatedly recreate the same size incision site in the patient.
0003Exemplary prior art insertion tools include those illustrated in US Patent Application Publication No. 2010/0094252 by Wengreen, et al., incorporated herein by reference in its entirety.
SUMMARY
0004Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
0005Exemplary embodiments provide subcutaneous implantation tools and methods of implanting a subcutaneous micro-device using the same. The invention provides a syringe-like tool, comprising a tool body, hereafter “handle”, having a hollow, distally longitudinally extending recess such as a bore or channel and having a distal opening through which the device may be delivered. The device preferably also includes a movable plunger located within the bore or channel. An incision tool is provided to make an incision through which the subcutaneous device is implanted.
0006The device may, for example, be implanted in the region of the thorax. A specific recommended location will typically be provided within an associated product manual. In one embodiment, two electrodes on the body of the device monitor the patient's subcutaneous ECG. The device may ECG recordings in response to patient activation or in response to automatically detected arrhythmias. Exemplary devices are disclosed in US Patent Application Publication No. 2009/0036917 by Anderson, US Patent Application Publication No. 2010/0094252 by Wengreen, et al., US Patent Application Publication No. 2012/0283705 by Hoeppner, et al., U.S. Pat. No. 5,987,352, issued to Klein, et al., U.S. Pat. Nos. 6,412,490 and 7,035,684 issued to Lee, et al. and U.S. Pat. No. 6,230,059, issued to Duffin, et al., all incorporated herein by reference in their entireties.
0007The incision tool is designed to create an incision of repeatable width and depth with a single motion. It is composed of a blade, designed to make a repeatable incision, and handle, designed to ergonomically fit the hand. The incision tool is intended to make the incision simple and repeatable. Other mechanisms for making openings in the patient's skin such as trocars, spreaders, scalpels and the like may be substituted in some alternative embodiments. The insertion tool delivers the device through the incision and into the subcutaneous tissue. The tool is designed to ensure the device is delivered into a tight pocket to maximize electrode contact with the surrounding tissue in a highly repeatable manner, and is composed of two parts: a handle and a plunger. The handle is composed of a bore or channel section, used to hold the device and guide it during implant, and a protrusion extending distally of the channel, used to bluntly dissect an implant path for the device to travel down while being implanted. The tunneler extends distally from the channel a position laterally displaced from the device when the device is located in the channel. The plunger is used to push the device distally out of the handle, through the incision, alongside and exterior to the tunneler and along the implant path created by the tunneler to the final implant location.
0008The device is typically loaded into the channel section of the insertion tool handle and sterile packaged along with both the insertion tool plunger and the incision tool.
0009The device is locatable within the channel distal to the plunger, so that when the plunger is moved distally, the device advances distally out of the tool body and into the tissue. Typically, the device will take the form of an elongated body, having a length greater than its thickness and width, as illustrated in the published Application No. 2010/0094252, cited above. The device may extend along its longitudinal axis between proximal and distal ends. The longitudinal channel or bore of the tool body may conform at least in part to the outer configuration of the device and more typically to a cross section of the device taken along its longitudinal axis. If the device, like the above discussed device, has a width greater than its depth and/or is otherwise radially asymmetric around its longitudinal axis, this feature allows the device to be advanced into the tissue while maintaining a desired orientation, as discussed in more detail below.
0010Optimally, the final insertion site of the device is located a short distance from the incision site. As noted above, the handle is preferably provided with an elongated protrusion or tunneler extending distally from the distal opening of the bore, which is insertable into the tissue through the incision to create a path in the tissue, along which the device may be advanced when pushed by the plunger. The distal end of the tunneler when so inserted is preferably located at the desired location of the distal end of the device. The length of the tunneler is thus preferably at least equal to and preferably somewhat greater than the length of the subcutaneous device.
0011Additional embodiments provide methods of implanting a subcutaneous micro-device, including inserting the dissection body of the tool described by the embodiments of the tool into an implantation site, where the dissection body includes a micro-device, and delivering the micro-device.
BRIEF DESCRIPTION OF DRAWINGS
0012Exemplary embodiments will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings. <figref idref="DRAWINGS">FIGS. 1-10</figref> represent non-limiting, example embodiments as described herein.
0013<figref idref="DRAWINGS">FIG. 1</figref> is a perspective view of an exemplary implantable device and the associated tool handle.
0014<figref idref="DRAWINGS">FIG. 2</figref> is a perspective view of the exemplary implantable device.
0015<figref idref="DRAWINGS">FIG. 3</figref> is a perspective view of the incision tool according to exemplary embodiments.
0016<figref idref="DRAWINGS">FIGS. 4A, 4B and 4C</figref> are top, side and bottom views, respectively, of the incision tool of <figref idref="DRAWINGS">FIG. 3</figref>.
0017<figref idref="DRAWINGS">FIGS. 5A and 5B</figref> are perspective views of the tool handle and plunger, respectively, according to exemplary embodiments of the invention.
0018<figref idref="DRAWINGS">FIGS. 6A, 6B, 6C, 6D and 6E</figref> are distal end, cut-away, top, bottom and proximal end views, respectively, of the tool handle.
0019<figref idref="DRAWINGS">FIGS. 7A and 7B</figref> are cross sectional views through the tool handle as illustrated in <figref idref="DRAWINGS">FIG. 6C</figref>.
0020<figref idref="DRAWINGS">FIGS. 8A, 8B, 8C and 8D</figref> are distal end, cut-away, top and proximal end views, respectively, of the plunger of <b>5</b>B.
0021<figref idref="DRAWINGS">FIGS. 9A, 9B, and 9C</figref> are cross sectional, side and bottom views, respectively, of the plunger as illustrated in <figref idref="DRAWINGS">FIG. 8D</figref>.
0022<figref idref="DRAWINGS">FIG. 10</figref> is a flow chart illustrating a method of delivering a device to a subcutaneous site according to exemplary embodiments.
DETAILED DESCRIPTION
0023Various exemplary embodiments will now be described more fully with reference to the accompanying drawings in which some exemplary embodiments are illustrated. In the drawings, the thicknesses of layers and regions may be exaggerated for clarity.
0024Accordingly, while exemplary embodiments are capable of various modifications and alternative forms, embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit exemplary embodiments to the particular forms disclosed, but on the contrary, exemplary embodiments are to cover all modifications, equivalents, and alternatives falling within the scope of the invention. Like numbers refer to like elements throughout the description of the figures.
0025It will be understood that, although the terms first, second, etc. may be used herein to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish one element from another. For example, a first element could be termed a second element, and, similarly, a second element could be termed a first element, without departing from the scope of exemplary embodiments. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items.
0026It will be understood that when an element is referred to as being “connected” or “coupled” to another element, it can be directly connected or coupled to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected” or “directly coupled” to another element, there are no intervening elements present. Other words used to describe the relationship between elements should be interpreted in a like fashion (e.g., “between” versus “directly between,” “adjacent” versus “directly adjacent,” etc.).
0027The terminology used herein is for the purpose of describing only particular embodiments and is not intended to be limiting of exemplary embodiments. As used herein, the singular forms “a,” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises,” “comprising,” “includes” and/or “including,” when used herein, specify the presence of stated features, integers, steps, operations, elements and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components and/or groups thereof.
0028Spatially relative terms, e.g., “beneath,” “below,” “lower,” “above,” “upper” and the like, may be used herein for ease of description to describe one element or a relationship between a feature and another element or feature as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the Figures. For example, if the device in the figures is turned over, elements described as “below” or “beneath” other elements or features would then be oriented “above” the other elements or features. Thus, for example, the term “below” can encompass both an orientation which is above as well as below. The device may be otherwise oriented (rotated 90 degrees or viewed or referenced at other orientations) and the spatially relative descriptors used herein should be interpreted accordingly.
0029It should also be noted that in some alternative implementations, the functions/acts noted may occur out of the order noted in the figures. For example, two figures shown in succession may in fact be executed substantially concurrently or may sometimes be executed in the reverse order, depending upon the functionality/acts involved.
0030Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which exemplary embodiments belong. It will be further understood that terms, e.g., those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
0031Exemplary embodiments are directed to subcutaneous implantation tools and methods of implanting subcutaneous micro-devices. <figref idref="DRAWINGS">FIGS. 1A to 10</figref> illustrate various exemplary embodiments of such subcutaneous implantation tools.
0032<figref idref="DRAWINGS">FIG. 1</figref> shows the implantable device <b>10</b>, aligned longitudinally with the handle <b>100</b>, arranged for the insertion of device <b>10</b> into the channel <b>102</b> of the handle <b>100</b>. The proximal end <b>20</b> of the device is inserted into the distal end <b>108</b> of the channel <b>102</b> of the handle and is advanced proximally until the proximal end <b>30</b> of the device is located adjacent an internal stop surface (not illustrated) within the handle <b>100</b>. At this point, the distal end <b>20</b> of the device will be adjacent the distal end <b>108</b> of the handle <b>100</b>. The open upper portion of the channel <b>102</b> allows visual verification that the device <b>10</b> is properly inserted into the channel. The tunneler <b>104</b> extends distally of the distal end <b>108</b> of channel <b>102</b>. The distal end <b>106</b> of the tunneler is placed into the incision made by the incision tool with its upper surface facing outward of the patient's body and advanced to provide blunt dissection of the subcutaneous tissue to a point where the distal end <b>20</b> of the device is adjacent the opening of the incision. The handle <b>100</b> is then rotated 180 degrees so that the tunneler <b>104</b> is then above the device (outward relative to the patient's skin). This allows upward pressure on the handle to assist in temporarily enlarging the incision and assures that the device will not escape as advanced distally into the tissue. The device <b>10</b> is then advanced by distal movement of the plunger illustrated in <figref idref="DRAWINGS">FIG. 5B</figref> within the channel <b>102</b> and along the tunneler <b>104</b> until it is properly located within the tissue, displaced distally a short distance from the opening of the incision. The logo <b>112</b> assists in reminding the physician to rotate the handle prior to insertion of the plunger and advancement of the device.
0033<figref idref="DRAWINGS">FIG. 2</figref> shows the device <b>10</b> in more detail. In this view it can be seen that the device comprises two electrodes <b>12</b> and <b>14</b>, located adjacent the proximal and distal ends, respectively, of the device. When implanted, electrode <b>12</b>, located on the upper surface <b>16</b> of the device preferably faces outward toward the skin. As such, when the device is placed into the handle as discussed above, the electrode <b>12</b> faces downward and is not visible through the open upper portion of the channel, allowing verification of proper insertion into the handle.
0034The exemplary device <b>10</b> as illustrated generally takes the form of an elongated rectangular prism having rounded corners and a rounded distal end portion. The rounded distal end of the device assists in allowing it to advance into body tissue, providing blunt dissection of the tissue as it advances. Because the cross section of the device is substantially greater than the cross section of the tunneler, the device will be located snugly within the tissue, reducing the chances for the formation of air bubbles adjacent the electrodes and also assisting in maintaining the device in its desired position. The device has length (L), width (W) and depth (D) as illustrated. In this particular embodiment, the with is greater than the depth, providing radial asymmetry along the longitudinal axis of the device and assisting in maintaining the device in its proper orientation with upper surface <b>16</b> facing outward after implant. A suture hole <b>18</b> may optionally be provided at the proximal end of the device to allow the physician to suture it to underlying tissue if desired. Projections <b>22</b> may optionally be provided to prevent longitudinal movement of the device after implant.
0035As discussed above, the inner surface of the channel of the handle is preferably configured to correspond to the outer configuration of the device. As discussed below in more detail, the configuration of the channel of the handle is configured to engage the rounded corners of the device, preventing rotation of the device within the handle.
0036<figref idref="DRAWINGS">FIG. 3</figref> illustrates the incision tool <b>200</b>, which is provided with a curved plastic handle <b>210</b> fitted with a flat, pointed blade <b>220</b> having a width equal to the desired width of the incision. The handle is designed to be comfortably held in a position allowing the blade to be advanced through the skin at a shallow angle, avoiding damage to underlying muscle tissue.
0037<figref idref="DRAWINGS">FIGS. 4A, 4B and 4C</figref> show top, side and bottom views of the incision device <b>200</b>. As illustrated in <b>4</b>A, both the differing coloration of the finger grips <b>234</b> and <b>232</b> and the placement of the logo <b>236</b> on the upper surface assist the physician in assuring that the orientation of the blade is correct to provide the desired shallow penetration angle.
0038<figref idref="DRAWINGS">FIGS. 5A and 5B</figref> show the handle <b>100</b> and the plunger <b>300</b> prior to insertion of the plunger into the handle. After rotation of the handle so that its upper surface bearing marking <b>112</b> now faces inward toward the patient's skin, the distal end <b>302</b> of plunger <b>300</b> is then inserted into an opening in the proximal end <b>110</b> of the handle and into the channel <b>102</b> of the handle.
0039The plunger is provided with a groove <b>306</b> running the length of the lower surface of the plunger up to a distal stop surface discussed below. The opening in the proximal end of the handle includes a protrusion corresponding to the groove in the lower surface of the plunger, assuring its proper orientation within the handle. A marking <b>308</b> adjacent the proximal end of the plunger assists the physician in determining that the plunger is in the proper orientation for insertion into the handle.
0040The plunger is advanced distally, pushing the device into the incision along the then inward facing surface of the tunneler. The device thus follows the path defined by the tunneler to assure proper placement within the tissue. After insertion of the device, the handle and plunger are removed.
0041Various medical grade materials may be used to form the various parts of the subcutaneous implantation tool, for example, plastics, metals, rubber, sanitizable materials, etc. Exemplary embodiments of the subcutaneous implantation tool may be inexpensive, disposable, etc. The subcutaneous implantation tool may also be configured to be used with known automated injection systems, which use, e.g., compressed air or other inert gases in place of a manual plunger.
0042<figref idref="DRAWINGS">FIGS. 6A, 6B, 6C, 6D and 6E</figref> are distal end, cut-away, top, bottom and proximal end views, respectively, of the tool handle <b>100</b>. In these views the projection <b>114</b> is visible. Projection <b>114</b> provides a distal facing stop surface limiting the insertion of the device <b>10</b> into the channel <b>102</b>. It further engages the slot in the lower surface of the plunger <b>300</b>, assuring proper orientation of the plunger within the handle. It also provides a proximal facing stop surface limiting distal movement of the plunger. The handle is also show as optionally provided with a slot <b>116</b> in its lower surface, through which advancement of the plunger and device can be observed.
0043<figref idref="DRAWINGS">FIGS. 7A and 7B</figref> are cross sectional views through the tool handle as illustrated in <figref idref="DRAWINGS">FIG. 6C</figref>. In these views, the arrangement of the inner corner surfaces <b>12</b>, <b>122</b>, <b>124</b> and <b>126</b> can be seen. These surfaces, along with side surfaces <b>128</b> and <b>130</b>, are arranged to generally correspond to the corners and the side surfaces of the device, preventing rotation of the device within the handle. The distal facing surface of projection <b>114</b> is also visible in this view.
0044<figref idref="DRAWINGS">FIGS. 8A, 8B, 8C and 8D</figref> are distal end, cut-away, top and proximal end views, respectively, of the plunger of <b>5</b>B. In these figures, the configuration of the groove <b>306</b> can be seen, along with distally facing stop surface <b>310</b>, which engages with the proximal facing surface of protrusion <b>114</b> of the handle, to limit distal movement of the plunger.
0045<figref idref="DRAWINGS">FIGS. 9A, 9B, and 9C</figref> are cross sectional, side and bottom views. Respectively, of the plunger as illustrated in <figref idref="DRAWINGS">FIG. 8D</figref>. In these views, the configuration of the groove <b>306</b> is visible in more detail.
0046<figref idref="DRAWINGS">FIG. 10</figref> is a flow chart illustrating a preferred embodiment of an insertion process according to the present invention. At <b>500</b>, the incision is made using the incision tool. At <b>510</b>, the handle carrying the device is inserted into the tissue such that the tunneler produces an elongated blunt incision along which the device may be advanced. In this step, the device is located outward of the tunneler relative to the patient's body. At <b>520</b> the handle, carrying the device is rotated so that the device is now inward of the tunneler relative to the patient's body. At <b>530</b>, the device is advanced by the plunger along the handle and along the then inward facing surface of the tunneler subcutaneously into the patient's body. Finally, at <b>540</b>, the handle and tunneler are removed.
0047Exemplary embodiments thus described allow for subcutaneous implantation of devices that are minimally invasive. Note that exemplary embodiments may be used in both human and animal patients.
0048Exemplary embodiments of the present invention being thus described, it will be obvious that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the exemplary embodiments of the invention, and all such modifications as would be obvious to one skilled in the art are intended to be included within the scope of the invention.
Contents4
11 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| USD1006990S | Cited by | United States of America | Applicant |
| US11857218B2 | Cited by | United States of America | Search report |
| US2020383702A1 | Cited by | United States of America | Search report |
| USD1042820S | Cited by | United States of America | Applicant |
| US12383305B2 | Cited by | United States of America | Search report |
| US2024032963A1 | Cited by | United States of America | Search report |
| CN1031481A | Cites | China | Applicant |
| US10786279B2 | Cites | United States of America | Applicant |
| US2001029386A1 | Cites | United States of America | Search report |
| JP2001502937A | Cites | Japan | Applicant |
| US2004082969A1 | Cites | United States of America | Applicant |
| US2004193154A1 | Cites | United States of America | Applicant |
| US2004249388A1 | Cites | United States of America | Applicant |
| WO2005044116A2 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| WO2005060306A1 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| US2005090852A1 | Cites | United States of America | Applicant |
| US2005096645A1 | Cites | United States of America | Applicant |
| US2005107768A1 | Cites | United States of America | Applicant |
| US2006074434A1 | Cites | United States of America | Applicant |
| US2006097331A1 | Cites | United States of America | Applicant |
| US2006106415A1 | Cites | United States of America | Applicant |
| US2006174898A1 | Cites | United States of America | Applicant |
| US2007010738A1 | Cites | United States of America | Applicant |
| US2007179515A1 | Cites | United States of America | Applicant |
| US2007249992A1 | Cites | United States of America | Applicant |
| JP2007516031A | Cites | Japan | Applicant |
| WO2008016551A1 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| US2008154298A1 | Cites | United States of America | Applicant |
| JP2008528084A | Cites | Japan | Applicant |
| US2009030426A1 | Cites | United States of America | Applicant |
| US2009036917A1 | Cites | United States of America | Applicant |
| US2009137946A1 | Cites | United States of America | Applicant |
| US2009393A | Cites | United States of America | Applicant |
| US2010030227A1 | Cites | United States of America | Applicant |
| US2010094252A1 | Cites | United States of America | Applicant |
| US2010198140A1 | Cites | United States of America | Applicant |
| US2010324578A1 | Cites | United States of America | Search report |
| US2010331868A1 | Cites | United States of America | Applicant |
| JP2011092065A | Cites | Japan | Applicant |
| WO2012098356A1 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| US2012283705A1 | Cites | United States of America | Applicant |
| US2014128963A1 | Cites | United States of America | Applicant |
| US2014276928A1 | Cites | United States of America | Applicant |
| US2016175007A1 | Cites | United States of America | Applicant |
| US2017258346A1 | Cites | United States of America | Applicant |
| US2020129206A1 | Cites | United States of America | Applicant |
| US2020383702A1 | Cites | United States of America | Applicant |
| US2021153895A1 | Cites | United States of America | Applicant |
| CN202342097U | Cites | China | Applicant |
| CN2621634Y | Cites | China | Applicant |
| CN2702718Y | Cites | China | Applicant |
| EP3034128A1 | Cites | European Patent Office (EPO) | Applicant |
| DE4243641A1 | Cites | Germany | Applicant |
| DE469951C | Cites | Germany | Applicant |
| US4915686A | Cites | United States of America | Applicant |
| US5127404A | Cites | United States of America | Applicant |
| US5304119A | Cites | United States of America | Applicant |
| US5484403A | Cites | United States of America | Applicant |
| US5562613A | Cites | United States of America | Search report |
| US5772671A | Cites | United States of America | Applicant |
| US5842999A | Cites | United States of America | Applicant |
| US5954670A | Cites | United States of America | Applicant |
| US5987352A | Cites | United States of America | Applicant |
| US6230059B1 | Cites | United States of America | Applicant |
| US6412490B1 | Cites | United States of America | Applicant |
| US7035684B2 | Cites | United States of America | Applicant |
| US8888745B2 | Cites | United States of America | Applicant |
| WO9813091A1 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| US20010029386A1 | Cites | United States of America | Search report |
| US20040082969A1 | Cites | United States of America | Applicant |
| US20040193154A1 | Cites | United States of America | Applicant |
| US20040249388A1 | Cites | United States of America | Applicant |
| US20050090852A1 | Cites | United States of America | Applicant |
| US20050096645A1 | Cites | United States of America | Applicant |
| US20050107768A1 | Cites | United States of America | Applicant |
| US20060074434A1 | Cites | United States of America | Applicant |
| US20060097331A1 | Cites | United States of America | Applicant |
| US20060106415A1 | Cites | United States of America | Applicant |
| US20060174898A1 | Cites | United States of America | Applicant |
| US20070010738A1 | Cites | United States of America | Applicant |
| US20070179515A1 | Cites | United States of America | Applicant |
| US20070249992A1 | Cites | United States of America | Applicant |
| US20080154298A1 | Cites | United States of America | Applicant |
| US20090030426A1 | Cites | United States of America | Applicant |
| US20090036917A1 | Cites | United States of America | Applicant |
| US20090137946A1 | Cites | United States of America | Applicant |
| US20100030227A1 | Cites | United States of America | Applicant |
| US20100094252A1 | Cites | United States of America | Applicant |
| US20100198140A1 | Cites | United States of America | Applicant |
| US20100324578A1 | Cites | United States of America | Search report |
| US20100331868A1 | Cites | United States of America | Applicant |
| US20120283705A1 | Cites | United States of America | Applicant |
| US20140128963A1 | Cites | United States of America | Applicant |
| US20140276928A1 | Cites | United States of America | Applicant |
| US20160175007A1 | Cites | United States of America | Applicant |
| US20170258346A1 | Cites | United States of America | Applicant |
| US20200129206A1 | Cites | United States of America | Applicant |
| US20200383702A1 | Cites | United States of America | Applicant |
| US20210153895A1 | Cites | United States of America | Applicant |
| First Office Action and Search Report, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Mar. 20, 2017, 18 pp. | Non-patent | – | Applicant |
54 members in 6 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201361788940 | United States of America | P | |
| 201414204227 | United States of America | A |
Members54
| Document | Office | Kind | |
|---|---|---|---|
| US2014276928A1 | United States of America | A1 | |
| WO2014150666A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CN105142551A | China | A | |
| EP2967644A1 | European Patent Office (EPO) | A1 | |
| DE202014010699U1 | Germany | U1 | |
| DE202014010700U1 | Germany | U1 | |
| DE202014010701U1 | Germany | U1 | |
| DE202014010702U1 | Germany | U1 | |
| DE202014010704U1 | Germany | U1 | |
| DE202014010706U1 | Germany | U1 | |
| DE202014010707U1 | Germany | U1 | |
| DE202014010708U1 | Germany | U1 | |
| DE202014010723U1 | Germany | U1 | |
| JP2016515021A | Japan | A | |
| DE202014010878U1 | Germany | U1 | |
| US2017258346A1 | United States of America | A1 | |
| JP6378746B2 | Japan | B2 | |
| EP2967644B1 | European Patent Office (EPO) | B1 | |
| JP2018183627A | Japan | A | |
| EP3420988A1 | European Patent Office (EPO) | A1 | |
| US10786279B2 | United States of America | B2 | |
| JP6772220B2 | Japan | B2 | |
| US2020383702A1 | United States of America | A1 | |
| US2021153895A1 | United States of America | A1 | |
| US2021267634A1 | United States of America | A1 | |
| US2021267635A1 | United States of America | A1 | |
| US2021267636A1 | United States of America | A1 | |
| US2021275221A1 | United States of America | A1 | |
| US11134985B2 | United States of America | B2 | |
| US11134986B2 | United States of America | B2 | |
| US11154323B2 | United States of America | B2 | |
| US11241253B2This record | United States of America | B2 | |
| US11311312B2 | United States of America | B2 | |
| USD957639S | United States of America | S | |
| USD967422S | United States of America | S | |
| USD976397S | United States of America | S | |
| USD979752S | United States of America | S | |
| CN116058940A | China | A | |
| USD997360S | United States of America | S | |
| USD997361S | United States of America | S | |
| US11779370B2 | United States of America | B2 | |
| USD1006990S | United States of America | S | |
| US11857218B2 | United States of America | B2 | |
| USD1010108S | United States of America | S | |
| EP3420988B1 | European Patent Office (EPO) | B1 | |
| EP3420988C0 | European Patent Office (EPO) | C0 | |
| US2024032963A1 | United States of America | A1 | |
| US2024041496A1 | United States of America | A1 | |
| EP4327766A2 | European Patent Office (EPO) | A2 | |
| EP4327766A3 | European Patent Office (EPO) | A3 | |
| USD1029269S | United States of America | S | |
| USD1032834S | United States of America | S | |
| USD1042820S | United States of America | S | |
| US12383305B2 | United States of America | B2 |
66 transactions on the USPTO file
Allowed without a rejection on record.
- Non-final rejections
- 0
- Final rejections
- 0
- RCEs
- 0
- Appeals
- 0
Over time
Point at a mark for the transactionTransactions
| Event | Code | |
|---|---|---|
| Payment of Maintenance Fee, 4th Year, Large EntityM1551 | M1551 | |
| Recordation of Patent Grant MailedPGM/ | PGM/ | |
| Patent Issue Date Used in PTA CalculationAllowedPTAC | PTAC | |
| Email NotificationEML_NTR | EML_NTR | |
| Issue Notification MailedAllowedWPIR | WPIR | |
| Dispatch to FDCD1935 | D1935 | |
| Application Is Considered Ready for IssuePILS | PILS | |
| Response to Reasons for AllowanceREAS | REAS | |
| Issue Fee Payment VerifiedN084 | N084 | |
| Issue Fee Payment ReceivedIFEE | IFEE | |
| Email NotificationEML_NTR | EML_NTR | |
| Mailing Corrected Notice of AllowabilityMCNOA | MCNOA | |
| Corrected Notice of AllowabilityCNOA | CNOA | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Pubs Case Remand to TCPUBTC | PUBTC | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Email NotificationEML_NTR | EML_NTR | |
| Mailing Corrected Notice of AllowabilityMCNOA | MCNOA | |
| Examiner's Amendment CommunicationEX.A | EX.A | |
| Reasons for AllowanceEX.R | EX.R | |
| Corrected Notice of AllowabilityCNOA | CNOA | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Interview Summary - Examiner Initiated - TelephonicEXET | EXET | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Pubs Case Remand to TCPUBTC | PUBTC | |
| Electronic ReviewELC_RVW | ELC_RVW | |
| Email NotificationEML_NTF | EML_NTF | |
| Mail Notice of AllowanceAllowedMN/=. | MN/=. | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Notice of Allowance Data Verification CompletedAllowedN/=. | N/=. | |
| Interview Summary - Examiner Initiated - TelephonicEXET | EXET | |
| Examiner's Amendment CommunicationEX.A | EX.A | |
| Reasons for AllowanceEX.R | EX.R | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Information Disclosure Statement consideredIDSC | IDSC | |
| Email NotificationEML_NTR | EML_NTR | |
| Change in Power of Attorney (May Include Associate POA)PA.. | PA.. | |
| Email NotificationEML_NTR | EML_NTR | |
| PG-Pub Issue NotificationPG-ISSUE | PG-ISSUE | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Track 1 Request GrantedT1GR | T1GR | |
| Mail-Record Petition Decision of Granted to Make SpecialMP003 | MP003 | |
| Case Docketed to Examiner in GAUDOCK | DOCK | |
| Email NotificationEML_NTR | EML_NTR | |
| Mail Pet Dec Track 1 GrantMPDTG | MPDTG | |
| Record Petition Decision of Granted to Make SpecialP003 | P003 | |
| Pet Dec Track 1 GrantPDTG | PDTG | |
| Email NotificationEML_NTR | EML_NTR | |
| Application ready for PDX access by participating foreign officesCCRDY | CCRDY | |
| Application Is Now CompleteCOMP | COMP | |
| Filing ReceiptFLRCPT.O | FLRCPT.O | |
| Application Dispatched from OIPEOIPE | OIPE | |
| FITF set to NO - revise initial settingFTFI | FTFI | |
| Information Disclosure Statement (IDS) FiledM844 | M844 | |
| Patent Term Adjustment - Ready for ExaminationPTA.RFE | PTA.RFE | |
| PTO/SB/69-Authorize EPO Access to Search ResultsSREXR141 | SREXR141 | |
| Applicants have given acceptable permission for participating foreignAPPERMS | APPERMS | |
| Track 1 RequestTK1R | TK1R | |
| Petition EnteredPET. | PET. | |
| Information Disclosure Statement (IDS) FiledWIDS | WIDS | |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change)BIG. | BIG. | |
| Initial Exam Team nnIEXX | IEXX |
12 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Maintenance fee paymentMAFP | MAFP | |
| Information on status: patent grantGrantedPATENTED CASESTCF | STCF | |
| Information on status: patent application and granting procedure in generalPUBLICATIONS -- ISSUE FEE PAYMENT VERIFIEDSTPP | STPP | |
| Information on status: patent application and granting procedure in generalPUBLICATIONS -- ISSUE FEE PAYMENT RECEIVEDSTPP | STPP | |
| Information on status: patent application and granting procedure in generalNOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONSSTPP | STPP | |
| Information on status: patent application and granting procedure in generalAWAITING TC RESP., ISSUE FEE NOT PAIDSTPP | STPP | |
| Information on status: patent application and granting procedure in generalNOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONSSTPP | STPP | |
| Information on status: patent application and granting procedure in generalAWAITING TC RESP., ISSUE FEE NOT PAIDSTPP | STPP | |
| Information on status: patent application and granting procedure in generalNOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONSSTPP | STPP | |
| Information on status: patent application and granting procedure in generalSPECIAL NEWSTPP | STPP | |
| AssignmentAS | AS | |
| Fee payment procedureENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITYFEPP | FEPP |
Numbers
- Publication
- 11241253
- Application
- 17329986
Titles
- English
- Subcutaneous delivery tool
Patent term adjustment
- Applicant delay
- −31 days
- Net adjustment
- 0 days
Classification
- CPC, 8
- A61B17/3468
- A61B17/32093
- A61B5/283
- A61B2017/320056
- A61B2017/320044
- A61N1/3756
- A61N1/37205
- A61B5/29
- IPC, 6
- A61B17 3209
- A61B17 32
- A61B17 34
- A61N1 375
- A61N1 372
- A61B5 283